enGene Therapeutics Inc. (ENGNW) Capital expenditures 2022–2025
enGene Therapeutics Inc. (ENGNW) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$1.5MFY2025 · since FY2022: $153,000 → $1.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.5M | +60.5% |
| FY2024 | $925,000 | +190.9% |
| FY2023 | $318,000 | +107.8% |
| FY2022 | $153,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice